» Articles » PMID: 10952621

Fluconazole Penetration into the Pancreas

Overview
Specialty Pharmacology
Date 2000 Aug 22
PMID 10952621
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Because of antibiotic prophylaxis for necrotizing pancreatitis, the frequency of fungal superinfection in patients with pancreatic necrosis is increasing. In this study we analyzed the penetration of fluconazole into the human pancreas and in experimental acute pancreatitis. In human pancreatic tissues, the mean fluconazole concentration was 8.19 +/- 3.38 microg/g (96% of the corresponding concentration in serum). In experimental edematous and necrotizing pancreatitis, 88 and 91% of the serum fluconazole concentration was found in the pancreas. These data show that fluconazole penetration into the pancreas is sufficient to prevent and/or treat fungal contamination in patients with pancreatic necrosis.

Citing Articles

Selective and Concentrative Enteropancreatic Recirculation of Antibiotics by Pigs.

Buddington K, Pierzynowski S, Holmes W, Buddington R Antibiotics (Basel). 2024; 13(1).

PMID: 38275322 PMC: 10812520. DOI: 10.3390/antibiotics13010012.


Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.

Novy E, Roger C, Roberts J, Cotta M Crit Care. 2023; 27(1):449.

PMID: 37981676 PMC: 10659066. DOI: 10.1186/s13054-023-04742-w.


Pancreatic candidiasis in a cat.

Renner K, Hill S, Grinberg A, Weeden A JFMS Open Rep. 2021; 7(2):20551169211052889.

PMID: 34691752 PMC: 8532232. DOI: 10.1177/20551169211052889.


Tissue penetration of antifungal agents.

Felton T, Troke P, Hope W Clin Microbiol Rev. 2014; 27(1):68-88.

PMID: 24396137 PMC: 3910906. DOI: 10.1128/CMR.00046-13.


Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics.

Eggimann P, Jamdar S, Siriwardena A Crit Care. 2006; 10(5):229.

PMID: 16959048 PMC: 1751041. DOI: 10.1186/cc5025.


References
1.
Rogers T, Galgiani J . Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 1986; 30(3):418-22. PMC: 180572. DOI: 10.1128/AAC.30.3.418. View

2.
Beger H, Bittner R, Block S, Buchler M . Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986; 91(2):433-8. DOI: 10.1016/0016-5085(86)90579-2. View

3.
Hughes C, Bennett R, Tuna I, Beggs W . Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrob Agents Chemother. 1988; 32(2):209-12. PMC: 172136. DOI: 10.1128/AAC.32.2.209. View

4.
Buchler M, Malfertheiner P, Friess H, Bittner R, Vanek E, Schlegel P . The penetration of antibiotics into human pancreas. Infection. 1989; 17(1):20-5. DOI: 10.1007/BF01643494. View

5.
Beger H . Surgical management of necrotizing pancreatitis. Surg Clin North Am. 1989; 69(3):529-49. DOI: 10.1016/s0039-6109(16)44834-6. View